Africa's HPV Vaccination Challenge: Misinformation, Hesitancy, and Hope

Cervical cancer has become a leading cancer killer among women in Africa, accounting for 23% of the deaths globally, while 18 of the 20 countries with the highest rate of cervical cancer cases in the world are in Africa. Despite the availability of the HPV vaccine, which can prevent the virus that causes most cases of cervical cancer, the region's vaccination rate has been low. Nigeria's Chinedu Asadu Yunusa Bawa experiences firsthand the challenge of combating misinformation about the HPV vaccine in rural areas, where unfounded rumors spread quickly, discouraging parents from vaccinating their daughters.

Key Takeaways:

• Across Africa, an average of 190 women died daily from cervical cancer in 2020, making it the leading cancer killer among women in the WHO Africa region of 47 countries.
• Eighteen of the 20 countries with the highest rate of cervical cancer cases in the world are in Africa, where the HPV vaccination rate has been low.
• Only five African countries have reached the 90% coverage that the continent hopes to achieve by 2030, and across the region, 33% of young girls have been vaccinated with HPV.
• Part of Africa's high burden of cervical cancer is due to limited access to screening for women, with the elimination strategy being a long game that requires a multi-faceted approach.
• The WHO's Africa office estimates that about 25% of the population still has doubts about the HPV vaccine, reflecting concerns seen in early campaigns.
• Success stories in Africa include countries like Rwanda, which has achieved a 90% vaccination rate through community outreach programs and school-based campaigns, and Ethiopia, which relies heavily on religious leaders and teachers to promote the vaccine.
• In Tanzania, the HPV vaccine has been in use since at least 2018, but coverage has only reached 80% of girls with the first dose, highlighting ongoing challenges in vaccine outreach.
• Nigeria has recently procured nearly 15 million doses of the HPV vaccine, which will be targeted at girls aged 9-14 in a campaign to raise coverage, which has been struggling due to low vaccine uptake.
• Dr. Aisha Mustapha, a gynecologist in northern Kaduna state, has successfully treated for cervical cancer and now leads the Medical Women Association of Nigeria, promoting the importance of the HPV vaccine through education and outreach programs.

Statistics:

• 190 women died daily from cervical cancer in Africa in 2020 (WHO Africa office)
• 18 of 20 countries with the highest rate of cervical cancer cases in the world are in Africa
• 33% of young girls have been vaccinated with HPV across the region (WHO Africa office)
• 5 African countries have reached the 90% coverage that the continent hopes to achieve by 2030
• 25% of the population still has doubts about the HPV vaccine (WHO Africa office)
• 90% vaccination rate achieved in Rwanda through community outreach and school-based campaigns
• 80% coverage rate with the first dose of the HPV vaccine in Tanzania
• 79% of girls have received the first dose of the HPV vaccine in Tanzania as part of a recent campaign
• 15 million doses of the HPV vaccine have been procured by Nigeria to target girls aged 9-14

Sources:

• "WHO Africa office"
• Nature science journal (study published in May)
• World Health Organization's Africa region
• Gavi (The Vaccines Alliance)
• Medical Women Association of Nigeria